Skip to main content

CORRECTION article

Front. Cardiovasc. Med., 12 May 2022
Sec. Cardiovascular Genetics and Systems Medicine
Volume 9 - 2022 | https://doi.org/10.3389/fcvm.2022.900621
This article is part of the Research Topic Epigenetic Regulation in Cardiac Remodeling and Vascular Diseases View all 8 articles

Corrigendum: The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years

This article is a correction to:

  1. The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years

    1. Read original article
\nChan WuChan WuBinghong LiuBinghong LiuRuiying Wang Ruiying Wang*Gang Li Gang Li*
  • Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China

A Corrigendum on
The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years

by Wu, C., Liu, B., Wang, R., and Li, G. (2022). Front. Cardiovasc. Med. 8:809580. doi: 10.3389/fcvm.2021.809580

In the published article, there was an error in affiliation 1. Instead of “School of Medicine, Cardiovascular Hospital of Xiamen University, Xiamen University, Xiamen, China,” it should be “Xiamen Cardiovascular Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: microRNAs, myocardial infarction, mechanisms, clinical application, review

Citation: Wu C, Liu B, Wang R and Li G (2022) Corrigendum: The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years. Front. Cardiovasc. Med. 9:900621. doi: 10.3389/fcvm.2022.900621

Received: 21 March 2022; Accepted: 21 April 2022;
Published: 12 May 2022.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Wu, Liu, Wang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ruiying Wang, wangruiying8866@163.com; Gang Li, ligang@xmu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.